Glutathione: the antioxidant system you already have
Glutathione is often called the master antioxidant. The real story is more useful: how your body makes it, what human studies have measured, and what those findings mean when you compare treatments.
An antioxidant your cells make
Glutathione is made from three amino acids: glutamate, cysteine and glycine. It helps maintain the chemical balance inside cells and is part of the systems that manage oxidative stress. Researchers can study its concentration, production rate and balance between reduced and oxidized forms. Those measurements describe different aspects of the system; none is a standalone score for how well someone is aging. Glutathione synthesis research.
What changes with age?
In a small 2011 study, eight older adults had lower red-blood-cell glutathione production and concentrations than eight younger adults. After the older group received the precursor amino acids cysteine and glycine for two weeks, several glutathione and oxidative-stress measurements improved. Read the study.
The finding connects precursor availability with glutathione biology. It does not establish a universal decline rate, or show that injecting glutathione produces the same results. The intervention was amino acid supplementation, and the study did not measure lifespan.
Can oral glutathione change body stores?
Yes, measurable changes have been reported. A six-month randomized trial in 54 nonsmoking adults found increases in glutathione stores in several measured compartments with oral supplementation. The results challenge the idea that oral glutathione is always destroyed before it can have any biological effect. They do not establish that an injection is more effective, or that higher levels reliably mean better energy or recovery. Read the oral supplementation trial.
Does a different delivery route mean a better result?
A delivery route changes the treatment. It does not settle whether the treatment works for a particular goal. A phase IIb study of intranasal glutathione in people with Parkinson disease found that the active-treatment groups were not superior to placebo. That disease-specific nasal study cannot establish wellness benefits for healthy adults or outcomes from subcutaneous injections. Read the nasal trial.
Our glutathione format comparison explains the differences. Look for research using the same ingredient, route and population as the option you are considering.
What a treatment decision should include
Decide what you want to address, how improvement would be assessed and whether the supporting research measures that outcome. Your clinician can consider those goals alongside your health history and medications.
AnthologyRX offers compounded glutathione after a clinical assessment. Compounded medication is not an FDA-approved finished product, and FDA does not evaluate it for safety, effectiveness and quality before marketing as it does approved drugs. Read FDA's compounding explanation.
Glutathione's role in the body is well worth understanding. Choosing a treatment requires another step: connecting the actual prescription to a realistic, measurable goal.
Sources
- Sekhar et al. Glutathione synthesis and precursor supplementation in older adults
American Journal of Clinical Nutrition, 2011. Eight older and eight younger participants; precursor supplementation in the older group.
- Richie et al. Oral glutathione and body stores
European Journal of Nutrition, 2015. Six-month randomized, placebo-controlled study in 54 adults.
- Mischley et al. Intranasal glutathione in Parkinson disease
Journal of Parkinson’s Disease, 2017. Phase IIb trial; active groups not superior to placebo.
- FDA: Compounding questions and answers
The distinction between compounded medications and FDA-approved drug products.




